$FRST

Primis Financial (NASDAQ:FRST) Upgraded to “Strong-Buy” at Raymond James Financial

Raymond James upgraded Primis Financial (NASDAQ:FRST) to a “Strong-Buy” rating, according to a research report cited by Zacks.com. The article notes other analysts’ mixed ratings and a consensus target price of $18.00. It also reports FRST’s April 23 earnings: EPS $0.33 vs $0.32 expected, revenue $45.63M vs $43.87M, plus a $0.10 quarterly dividend.

Original reporting
Published Jun 27, 2026, 11:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 27, 2026, 11:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Primis Financial (NASDAQ:FRST) Upgraded to “Strong-Buy” at Raymond James Financial — source image
Decision brief

The 30-second read

$FRSTBullishMed
01

Why it matters

For FRST, the actionable element is the new “strong-buy” rating; the rest is context (prior earnings beat, dividend paid, and institutional ownership changes) rather than new disclosures.

02

Market read

Traders may use the upgrade as a short-term catalyst, but the article does not provide new fundamental datapoints that would justify a high-conviction repricing.

03

What to watch

Small-cap bank moves can reverse if credit quality, deposit trends, or funding costs deteriorate; none of those are updated here, so traders should not over-weight the upgrade versus upcoming bank-specific metrics.

Relevance 6/10Novelty 5/10Timing: upgrade report cited as sent to investors on Thursday

Background

The piece reports an analyst action (Raymond James upgrade) and summarizes other recent rating changes, plus dated earnings and dividend information.

Company-level read

Ticker impact

$FRSTBullishMedium confidence
Context

Raymond James upgraded Primis Financial to a “strong-buy,” while the article also cites recent earnings beat and a declared quarterly dividend.

Expected impact

Likely modest positive bias for FRST around the upgrade, with follow-through dependent on broader analyst revisions and upcoming earnings.

Evidence & confidence

Analyst rating upgrades can move small/mid-cap bank stocks, but the text lacks fresh guidance, filings, or transaction-specific news; it mainly aggregates ratings plus already-dated earnings/dividend facts.

Market effects

Adds incremental positive sentiment for regional/community bank coverage, but no sector-wide policy or credit-cycle datapoint is introduced.

Primis is Georgia-focused; no new regional economic or regulatory development is provided.

No global macro linkage beyond general equity sentiment.

Counterpoint

The upgrade may be largely incremental because the article does not introduce new earnings/guidance or balance-sheet changes—only a rating shift and recap of prior results.

Key entities

  • Primis Financial

    NASDAQ-listed bank holding company; subject of the Raymond James upgrade and the dividend/earnings recap.

  • Raymond James Financial

    Issued the “strong-buy” upgrade referenced in the article.

Related articles

$FRSTMed

Primis Financial Corp. Reports Strong Results for the Second Quarter of 2026

Primis Financial Corp. (NASDAQ: FRST) reported Q2 2026 net income available to common shareholders of $9.4 million, or $0.38 per diluted share, versus $2.4 million, or $0.10, in Q2 2025. Six-month net income was $16.7 million, or $0.68 per diluted share. The company also declared a $0.10 quarterly cash dividend and cited improvements including ROA, lower NPAs, and a $6.1 million earnings impact from a core conversion.

$FRSTMed

Primis Financial Corp. (FRST): Results of Operations and Financial Condition

Primis Financial Corp. (FRST) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2621139d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Primis Financial Corp. Reports Strong Results for the Second Quarter of 2026 Declares Quarterly Cash Dividend of $0.10 Per Share For immediate release Thursday, July 23, 2026 McLean, Virginia, July 23, 2026 – Primis Finan

$TSNMed

Stocks making the biggest moves midday: Tesla, Ciena, Meta, Snowflake, Ultragenyx Pharmaceutical & more

Tyson Foods fell 7% after cutting fiscal 2026 guidance. Meta rose 3% on AI model launch. Dell gained 5% post-earnings. Crypto-related stocks climbed with bitcoin. Robinhood jumped 15% on Deutsche Bank's report. Ciena dropped 9% despite beating estimates. Tesla advanced 6% ahead of Cybercab event. Snowflake surged 22% on strong earnings. HPE slipped 4% with lower-than-expected growth forecast. Broadcom lost 3% on weak revenue outlook. Campbell's fell 9% on lagging guidance. Ultragenyx plunged 44%

$MC.PAMed

European stocks recover from one-month lows as bond yields retreat

European stocks rose 0.5% on Thursday, recovering from one-month lows, as bond yields retreated. Soitec surged 10.3% after raising its 2027 revenue growth outlook to 50%. Investors await U.S. economic data for Fed policy clues. Oil prices eased but remained high, impacting European equities. ECB is expected to raise rates to 2.5% next week. WPP and Publicis gained on media account win news, while luxury stocks fell.